Court Debates Disability in Drug Case
6th Circuit says employees aren't disabled under ADA.
December 31, 2010 at 07:00 PM
5 minute read
Employers know that, despite preventive measures, accidents can happen. But accidents involving employees who might be under the influence have particular gravity, as they can indicate or lead to larger problems.
At Dura Automotive Systems Inc.'s Lawrenceburg, Tenn., facility, employees routinely assembled vehicle windows, tested products and drove forklifts. When the plant's accident rate surpassed that of comparable plants, management suspected that drug use–illegal or legal–might be to blame.
Dura instituted a policy that forbade employees from using legal prescription drugs that could jeopardize performance or safety. An independent testing company screened employees for 12 substances, including some found in legal medications. Forty-four of the 500 screened employees tested positive for prescription drugs containing the banned substances. Dura ordered the employees to take a 30-day leave of absence, and upon their return, required them to pass another test to stay with the company.
Seven employees with legal prescriptions procured doctors' notes stating that their performance wouldn't be affected by their medication. Dura wouldn't accept the notes and told the employees they could instead transition to drugs without the prohibited substances. The employees didn't comply and were terminated; they sued Dura for violating Section (b)(6) of the Americans With Disabilities Act (ADA).
On Nov. 3, 2010, the 6th Circuit ruled in Dura's favor in Bates v. Dura Automotive Systems Inc. In his opinion, Judge Boyce Martin asserted that the plaintiffs were not disabled and therefore were not covered by Section (b)(6).
Determining Disability
The ADA defines disability as an impairment substantially limiting major life activities. Section (b)(6) prohibits discrimination against “a qualified individual with a disability because of the disability” by using “qualification standards, employment tests or other selection criteria that screen out or tend to screen out an individual with a disability,” unless the test is job-related and necessary for the position.
The district court found that the plaintiffs weren't disabled because they couldn't prove their ailments limited their ability to work, which is a major life activity. When the court didn't dismiss the plaintiffs' claims, Dura motioned for clarification on whether a person must be disabled to pursue a claim under (b)(6). The district court ruled that nondisabled people can sue under (b)(6) but certified the issue for appeal.
The 6th Circuit scrutinized the language of (b)(6) and determined that it only protects disabled individuals. The court reversed and remanded the district court's decision and ordered the dismissal of the plaintiffs' claims.
However, the case was tried under the original ADA definition of disability. The ADA Amendments Act, which took effect on Jan. 1, 2009, substantially changed this definition. Thus a similar case filed now may well have a different outcome (see “Broader Qualifications”).
“The ADA Amendments [Act] will make it easier for people to classify themselves as disabled,” says Brian Hall, a partner at Porter Wright Morris & Arthur. The amendments expand the list of major life activities to include an array of tasks, such as bending, concentrating and sleeping.
Users and Abusers
The changes in the ADA's definition of disability and state-specific testing laws can make it challenging for employers to confidently establish drug policies. “If you're an employer with employees in all 50 states, it really is an administrative headache,” says Kathryn Russo, a partner at Jackson Lewis and leader in the firm's Drug Testing & Substance Abuse Management Practice Group.
But Russo says that shouldn't discourage employers. “If you have people abusing prescription drugs, they are very well creating a dangerous workplace,” she says. Employees are increasingly testing positive for painkillers such as Vicodin and Oxycontin, and although these drugs are legal when obtained with prescriptions, they're as addictive as other commonly abused drugs in the workplace, including marijuana, cocaine, methamphetamines, Ecstasy and opiates.
Drug-test provider Quest Diagnostics reported a 40-percent increase in employees testing positive for opiates from
2005 to 2009 and an 18-percent increase from 2008 to 2009 alone. Workers involved in accidents are four times more likely to test positive for opiates.
Hall says the key to initiating workplace testing is communicating safety concerns to employees. “It's important to demonstrate the real necessity for it,” he says.
There are two kinds of drug-testing methods: reasonable suspicion, which tests an employee whose behavior mirrors that of someone under the influence; and random, which periodically tests a randomly selected group of employees. Russo says only a qualified medical review officer should analyze employee tests. To comply with ADA, employers should individually assess employees who test positive for legal prescription drugs and determine if the medications directly threaten safety or if reasonable alternative accommodations should
be made.
Some employers may be hesitant to test for prescription drugs because of sensitive stereotypes associated with specific medications and the possibility that drugs are being taken for conditions that qualify as disabilities.
“If an employer really wants to be conservative, they may want to stick with just testing for illegal drugs; you won't run into any ADA issues,” says Russo. “The problem with deciding to test for prescription drugs is doing it correctly and making sure you don't make overly generalized conclusions when someone tests positive.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllSEC Puts Beat Down on Ex-Wrestling CEO Vince McMahon for Not Reporting Settlements
3 minute readMeta Hires Litigation Strategy Chief, Tapping King & Spalding Partner Who Was Senior DOJ Official in First Trump Term
Trending Stories
- 1Lavish 'Lies' Led to Investors Being Fleeced in Nine-Figure International Crypto Scam
- 2AstraZeneca Files Flurry of Lawsuits to Protect Cancer Treatment Drug
- 3American Airlines Legal Chief Departs for Warner Bros. Discovery
- 4New Montgomery Bar President Aims to Boost Lawyer Referral Service
- 5Deadline Extended for Southeastern Legal Awards
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250